COVID-19 booster dose study by the Center in progress; 1200 participants get a 3rd jab: Sources

In a big development, sources told Republic TV that a study to determine the need to introduce a booster dose policy in India is already underway. According to the sources, around 3,000 double-vaccinated people who took their last dose more than 6 months ago are participating in this study conducted by the Department of Biotechnology. Participants can be broadly classified into 4 categories: those under 40, those over 40, those who have been infected with COVID-19 in the past, and those with co-morbidities.

1,200 participants have already received the booster dose so far, sources revealed. This is growing in importance amid a growing demand from various sections of society to allow fully vaccinated individuals to take the third dose of a vaccine amid the threat of the Omicron variant. A day earlier, the Indian Medical Association also wrote to Prime Minister Modi requesting booster doses for the medical fraternity.

Speaking exclusively to Republic TV on the latest developments, IMA President JA Jayalal said, “The timeline has to be there to know when the results will be released. And how long are you going to wait. is spreading rapidly. The doubling time in India right now is 2.5 to 3 days. This week we are going to have more cases, so we cannot ignore it. The study has already started. And I am sure that in a short time the results will come and the government can implement. At the same time, we also insist on mass vaccination. “

Vaccination against COVID-19 in India

At present, there are 77,516 active cases of the coronavirus in India, while 3,42,15,977 patients have recovered and 4,79,133 deaths have been reported. The improvement in the COVID-19 situation in India has been attributed to rapid advances in immunization. The country’s COVID-19 vaccination campaign began on January 16 with the vaccination of health workers in the first phase. This was opened to frontline workers on February 2 while people over 60 and over 45 with co-morbidities became eligible for vaccination from March 1.

While anyone over the age of 45 could get the vaccine starting April 1, all adults were added to the immunization coverage category on May 1. In a big success, India completed the administration of one crore of doses of the coronavirus vaccine on October 21. In addition to Covishield and Covaxin, the Drugs Controller General of India has approved Sputnik V, Moderna, the Janssen vaccine from Johnson & Johnson and the ZyCoV-D from Zydus Cadila. In total, 83,52,30,309 citizens were vaccinated while 57,16,77,266 of them also received the second dose of the vaccine.


Source link

Comments are closed.